Home > Clinical Trials

Saved trials

RECRUITING
NCT07478991
Azacytidine, Venetoclax Plus Minus Quizartinib for First Line Older/Unfit AML Patients (VENP-A-QUI)
376 Enrollment(s)
51 Study location(s)
INTERVENTIONAL (PHASE3)
Acute Myeloid Leukemia, Adult
RECRUITING
NCT07060807
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
1,000 Enrollment(s)
199 Study location(s)
INTERVENTIONAL (PHASE3)
Breast Neoplasms
COMPLETED
NCT06711978
Comparison of the Efficacy and Safety of Mirogabalin and Duloxetine in Chemotherapy-induced Peripheral Neuropathy in a Randomized Controlled Trial: a Quality of Life Study in Cancer Survivors
66 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (NA)
CIPN
CIPN - Chemotherapy-Induced Peripheral Neuropathy
CIPN in Adjuvant Breast Cancer Patients
Duloxetine
Mirogabalin
RECRUITING
NCT06533826
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
357 Enrollment(s)
11 Study location(s)
INTERVENTIONAL (PHASE2)
Breast Cancer


HER2-low Breast Cancer


Metastatic Breast Cancer


HER2-negative Breast Cancer
NOT_YET_RECRUITING
NCT07785856
Study of Trastuzumab Deruxtecan (T-DXd) in Combination With a RAGE Inhibitor in Patients With T-DXd-Resistant HER2-Positive or HER2-Low Metastatic Breast Cancer
27 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE1|||PHASE2)
T-dxd Resistant HER2-Positive


HER2 Low Metastatic Breast Cancer
RECRUITING
NCT07124000
DESTINY-PANTUMOUR04
100 Enrollment(s)
18 Study location(s)
OBSERVATIONAL (None)
Adenocarcinoma (NOS)


Anal Cancer


Bladder Cancer


Cervical Cancer


Endometrial Cancer


Esophageal Cancer


Gall Bladder Cancer


Gastrointestinal Stromal Tumour


Head and Neck Cancer


Liver Cancer


Melanoma


Mouth Cancer


Nasopharangeal Cancer


Neuroendocrine, Gastrointestinal Cancer


Ovarian Cancer


Pancreatic Cancer


Prostate Cancer


Renal Cell Carcinoma


Salivary Gland Cancer


Sarcoma


Small Cell Lung Cancer


Testicular Cancer


Throat Cancer


Thyroid Cancer


Urethral Cancer


Vaginal Cancer


Vulvar Cancer
TERMINATED
NCT03820947
VenaSeal Spectrum: Global Post-Market Randomized Controlled Trial
506 Enrollment(s)
32 Study location(s)
INTERVENTIONAL (NA)
Venous Reflux
NOT_YET_RECRUITING
NCT07782086
A Study of T-DXd in AI-Assessed HER2-Ultralow Metastatic Breast Cancer
30 Enrollment(s)
14 Study location(s)
INTERVENTIONAL (NA)
Breast Cancer